Nexalin Technology, a leading provider of advanced medical devices, has recently named Carolyn Shelton as their new Senior Vice President of Clinical, Quality & Regulatory Affairs. Shelton brings with her a wealth of experience and knowledge in the healthcare industry, making her a valuable addition to the Nexalin team.
In her new role, Shelton will be responsible for overseeing all clinical operations, ensuring quality control measures are in place, and managing regulatory affairs for the company. With over 20 years of experience in clinical research and regulatory affairs, Shelton is well-equipped to lead Nexalin in achieving their goals of providing safe and effective medical devices to patients worldwide.
Prior to joining Nexalin, Shelton held various leadership positions in the healthcare industry, where she successfully led teams in developing and executing clinical trials, obtaining regulatory approvals, and ensuring compliance with quality standards. Her expertise will be instrumental in driving Nexalin’s growth and expansion in the medical device market.
Nexalin Technology is known for its innovative approach to treating a variety of medical conditions, including anxiety, depression, and insomnia, using non-invasive neuromodulation technology. With Shelton at the helm of the clinical, quality, and regulatory departments, the company is poised to continue developing cutting-edge medical devices that improve the lives of patients around the world.
“We are thrilled to have Carolyn Shelton join our team as Senior Vice President of Clinical, Quality & Regulatory Affairs,” said a spokesperson for Nexalin Technology. “Her extensive experience and expertise will be invaluable as we work towards expanding our product offerings and reaching more patients in need of innovative medical solutions.”
Source
Photo credit news.google.com